Help raise awareness about arthritis during #WorldArthritisDay! Since 1996, World Arthritis Day on October 12th has unified people of all ages, races, and genders to raise awareness of rheumatic and musculoskeletal diseases (RMDs). On this day, we strive to raise awareness and share information and support with RMD patients and their caregivers. This year’s theme, “Don’t Delay, Connect Today,” initiated by EULAR, aims to highlight the importance of early diagnosis of RMDs. Together, we can work together towards earlier diagnosis and timely access to care!
As the Champion of Yes, the Arthritis Foundation moves forward every day in ways to improve access to care, providing new information and supporting scientific advancements to find a cure. We strive to provide many ways for those with arthritis and their loved ones with ways to keep saying Yes to life – including valuable tools and resources, such as toolkits you can access on the go, a 24/7 helpline, and access to local resources that will help you conquer everyday challenges.
Continue reading October 12 is World Arthritis Day
As an organization, we have always supported and encouraged the active involvement of patients in their own care. Patient perspectives matter greatly when it comes to decisions being made about health care. Their voices are vital in the clinical research process as new medications are being developed and tested.
Patient perspectives play a large role in Dr. Nora Singer’s 3-year Arthritis Foundation-funded project – “Cell-based therapy in systemic onset JIA (sJIA) refractory to conventional “c” and biological “b” DMARDs”. Her project uses stem cells derived from adult cells that are designed to “reset” the immune system. The study will compare the safety and effectiveness of the stem cell treatment to conventional and biological disease-modifying antirheumatic drugs (DMARDs). Currently, stem cell therapy is experimental in the U.S. and regulated by the U.S. Food and Drug Administration (FDA), but is less regulated in other countries.
Continue reading Researchers on the Path to a Cure – Spotlight on Dr. Nora Singer
Living Made Easier is a series of events that will show you how you CAN beat those daily obstacles created by arthritis and say Yes more than No – from cooking to gardening to daily living. You’ll get advice from local experts on how to reduce stress on your joints while maintaining the activities that you love.
Coming this fall, 2017, we will host Cooking Made Easier events in five cities across the country. This free, 90 minute and interactive program will be facilitated by local experts. During the program, two delicious side dishes will be cooked with samples provided to guests. In addition, guests will hear from other people who have arthritis about their cooking techniques and have the opportunity to share their own tips and tricks.
Continue reading Living Made Easier – Helping You Maintain Activities You Love
In mid-September, pop singer and songwriter Lady Gaga announced she was postponing the European leg of her world tour until early 2018 due to “severe physical pain.” She explained on Twitter, “I have to be with my doctors right now so I can be strong and perform for you all for the next 60 years or more.”
Six days later, she disclosed that the pain witnessed by viewers of the new Netflix documentary Gaga: Five Foot Two is from fibromyalgia, a condition associated with widespread chronic pain, fatigue, memory problems and mood changes.
Continue reading Lady Gaga Shines a Spotlight on Fibromyalgia
Ninety percent of people in the United States who have the chronic autoimmune disease lupus are women and, according to two new studies published recently in Arthritis & Rheumatology, large proportions are Hispanic or Asian. Like African-Americans, these two ethnic/racial groups are not only at higher risk of lupus than whites, they’re also more likely to have aggressive forms of the disease, researchers in New York and San Francisco found.
Lupus, or systemic lupus erythematosus (SLE), an affect virtually every organ system, and symptoms vary widely. Some patients have relatively mild skin and joint symptoms that may go into remission for long periods. Others have cognitive (neuropsychiatric) manifestations or life-threatening complications such as lung, heart and kidney problems.
Continue reading Lupus Strikes Some Groups of Women Harder and More Often
While St. Patrick’s Day might be months away, Arthritis Foundation supporters in nine different markets are painting the town green in honor of over 50 million Americans and 300,000 kids living with arthritis.
The Arthritis Foundation recently launched the fall Give Green, Get Green for Arthritis fundraising campaign to generate awareness and raise vital funds to find a cure for arthritis. The Give Green, Get Green campaign has kicked off in New York City (NY), Baltimore (MD), Louisiana, Montgomery (AL), South Florida, Cleveland (OH), Cincinnati (OH), Phoenix (AZ) and Minneapolis (MN). Local markets are looking to recruit “Champion Greenies” who can raise a minimum of $1,500 by engaging their network, staff, colleagues, friends and family.
Continue reading Give Green, Get Green for Arthritis
A big study published in 2016, called the PRECISION trial, found that people with arthritis who take the anti-inflammatory drug ibuprofen are more likely to develop cardiovascular problems than those using celecoxib – and now researchers think they know why. Ibuprofen raises blood pressure, according to new findings presented recently at the annual meeting of the European Society of Cardiology in Barcelona.
Continue reading Ibuprofen May Raise Heart Risk More Than Other NSAIDs
The number of biosimilars approved by the Food and Drug Administration (FDA) continues to grow in the United States, and they are slowly becoming available to consumers.
In late August, the FDA approved Cyltezo (adalimumab-adbm), a second biosimilar to Humira (adalimumab). But like the first biosimilar, Amjevita (adalimumab-atto), which was approved in September 2016, it is not yet available to U.S. consumers because of pending patent litigation with AbbVie, the manufacturer of Humira.
Continue reading FDA Approves A Fifth Biosimilar for Arthritis, But Three Are Still Not Available
You’ve worked hard for decades – and it’s about time to enter the next phase of your life. You’ll have time to catch up on those books you’ve been meaning to read, travel to places you’ve dreamed of visiting and perhaps volunteer for that charity you’ve always admired.
But a pleasurable retirement requires sound financial planning. How can you be sure you’ll continue receiving the lifetime income you need and not have to worry that you’ll have enough?
Continue reading Benefit From a Charitable Gift Annuity While Doing Good
During a natural disaster, not having your medications or assistive devices adds to physical and emotional stress, which can trigger arthritis flares and leave you vulnerable to injury and infection.
“High stress levels make rheumatic conditions worse; having an established emergency plan can only reduce stress,” says Jennifer Hootman, PhD, an epidemiologist in the Arthritis Program at the Centers for Disease Control and Prevention in Atlanta, Georgia. Registered nurse Victoria Ruffing, director of nursing and patient education at the Johns Hopkins Arthritis Center in Baltimore, MD, also stresses the need to have a plan for your medications – and awareness of the potential dangers for people with arthritis of the storm’s aftermath.
“Contaminated water, debris, and other post-hurricane conditions mean environments are ripe for infection and injury,” she says. “People should be on the alert for these and, if they pick up a bacterial or viral infection or have a wound that’s not healing well, they should seek medical care as soon as possible. This will probably mean going to an emergency department, but they should not put off seeking care – in disaster conditions medical problems can get worse very quickly.”
Continue reading Preparing for Irma if You Have Arthritis